From prospective studies evidence has accumulated that increased levels of C3 and CRP can predict T2DM and coronary events and could be candidate biomarkers for a pathological state preceding the ultimate disease [3], [8], [26], [27]. This evidence concerns the gene C3 and type 2 diabetes mellitus.